Streetbeat News

Partnerships

BLUE

bluebird bio, Inc. (NASDAQ:BLUE) announced its first Medicaid outcomes-based agreement for LYFGENIA, a gene therapy for sickle cell disease, with Michigan Medicaid. This agreement, focusing on equitable access for Medicaid-insured patients, represents a significant step in bluebird bio's commercial strategy. LYFGENIA offers a one-time treatment for patients 12 and older with a history of vaso-occlusive events. bluebird is in discussions with over 15 Medicaid agencies and has agreements with national commercial payers covering 200 million U.S. lives. The company is also engaged with CMMI for a demonstration model starting in 2025.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:14 pm

MIND

MIND Technology's Seamap unit has been awarded an order by ATLAS MARIDAN, indicating a positive development for MIND and potentially boosting its financial performance.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:14 pm

CLPT

ClearPoint Neuro, Inc. (NASDAQ:CLPT) announced preclinical results published in the Journal of Neurosurgery showing the ClearPoint Prism Neuro Laser Therapy System's accuracy and efficacy in brain tissue temperature measurement and lesion morphology. Conducted with Swedish partner Clinical Laserthermia Systems AB and led by Dr. John Rolston, the study supports the system's safety and precision, contributing to FDA clearance. The Prism System, featuring non-cooled neurosurgical laser applicators, simplifies neurosurgical procedures and is in limited release in the US.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:12 pm

SVRE

SaverOne 2014 Ltd. (NASDAQ:SVRE) has expanded its collaboration with GB Tours, installing the SaverOne System across GB Tours' full fleet of public transportation and tour buses in Israel. This follows a successful pilot on 20 buses, with an additional 77 buses to be equipped. The system aims to enhance passenger safety by minimizing traffic accident risks, marking a significant step in SaverOne's growth in the public transportation sector.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:08 pm

NTNX

WIT

Wipro has expanded its partnership with Nutanix to launch a new business unit aimed at accelerating digital transformation and hybrid multicloud innovation for their mutual clients.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:07 pm

PETV

PetVivo Holdings, Inc. has announced the appointment of Garry Lowenthal as its new Chief Financial Officer. Lowenthal brings over 25 years of experience in senior operations and finance management roles across both private and public companies. His background includes significant expertise in equity capital raising transactions, financial and corporate management, and serving in advisory roles for various organizations. PetVivo, an emerging biomedical device company focused on companion animals and animal athletes, expects Lowenthal's expertise to further its mission and enhance shareholder value.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:07 pm

LCTX

Lineage Cell Therapeutics, Inc. (LCTX) announced that preclinical results for OpRegen will be presented at the 2024 ARVO meeting. OpRegen, developed in collaboration with Roche and Genentech, is a treatment for geographic atrophy secondary to age-related macular degeneration. The study shows OpRegen's engraftment in the retinal pigmented epithelium of mini-pigs, indicating potential benefits for retinal health and function. The presentation will highlight the survival and distribution of OpRegen post-administration.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:06 pm

J

Jacobs Solutions Inc (NYSE:J) and Mott MacDonald have been chosen by Thames Water to support the delivery of its $5.9 billion asset investment programs. This eight-year deal involves technical, engineering, and planning services for major water infrastructure projects in the UK. Jacobs recently reported a 9.5% YoY revenue growth and an adjusted EPS of $2.02 for the first quarter of FY24.

Portfolio Pulse from Lekha Gupta

March 11, 2024 | 12:05 pm

GETR

Getaround (NYSE:GETR) announced the promotion of AJ Lee to Chief Operating Officer. Lee, previously General Manager of Gig, will focus on accelerating the company's growth and path to profitability, overseeing operations, marketing, sales, and more. Lee's promotion follows his successful tenure managing Getaround's Drive With Uber program and the HyreCar business, post-Getaround's acquisition of HyreCar, Inc.'s assets in May 2023. Lee's experience includes significant roles at Airspace, NEXT Trucking, and Amazon, where he demonstrated a strong track record of driving results and operational excellence.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:04 pm

BIVI

BioVie announced the completion of a funding round aimed at advancing its clinical priorities in Parkinson's Disease, Alzheimer's Disease, and Ascites/Liver Disease. The company is also exploring longevity and aging with partners.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 12:02 pm